In addition, specific analysis of locoregional lymph node status based on the risk of distant metastases and tumor biological profile revealed that 64% (9 of 14) of HER2-positive patients with axillary disease developed distant metastases compared with 25% (1 of 4) of patients with N0 disease. This evidence concerns the gene ERBB2 and neoplasm.